Confirmed Control (100%) Announced Transaction verified HealthcarePharmaPharmaceutical Manufacturing

E-Pharma Trento acquired by Wise Equity

Wise Equity agreed to acquire E-Pharma Trento, an Italian pharmaceutical manufacturing brand. Financial terms were not publicly disclosed. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.

Transaction summary

Target
E-Pharma Trento
Acquirer
Wise Equity
Seller
-
Announced
-
Geography
Italy
Tags
HealthcarePharmaPharmaceutical Manufacturing
Type
Acquisition
Deal type
Control
Stake acquired
100%
First added
2026-08-08
Latest update
2026-08-08

Parties at the deal date

Acquirer

Wise Equity

E-Pharma Trento will possibly explore bolt-on acquisitions to add new technologies or enhance its manufacturing capacity. The post Wise Equity inks agreement to acquire E-Pharma Trento appeared first on PE Hub . ]]>

Snapshot preserved for this transaction; current company profiles may differ.

Value and multiples

Price / value

Undisclosed

Transaction value

Basis: FundComb estimate

EV / revenue

-

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • Financial terms were not disclosed in the public sources reviewed.

Source summary

Wise Equity inks agreement to acquire E-Pharma Trento | PE Hub

Confirmed

PE Hub reports Wise Equity signed an agreement to acquire E-Pharma Trento, which may pursue bolt-on acquisitions to add technologies or enhance manufacturing capacity.

Open source